LITE · Q2 2026 Earnings
BullishLumentum
Reported February 3, 2026
30-second summary
Lumentum beat its own Q2 guide on every line — revenue $665.5M (+65.5% YoY, +24.7% QoQ), non-GAAP EPS $1.67 vs. a $1.30–$1.50 guide, non-GAAP operating margin 25.2% vs. a 20.0–22.0% guide — and then guided Q3 to $780–830M revenue and 30.0–31.0% operating margin, implying ~480–590bps of further margin expansion in a single quarter. The pricing lever flagged as "upside not embedded" for two consecutive quarters has now visibly turned on: non-GAAP gross margin moved to 42.5%, clearing the 40% target, with management telling Raymond James gross margins are "moving into the 40s for the first time."
Headline numbers
EPS
Q2 FY2026
$1.67
Revenue
Q2 FY2026
$0.67B
+65.5% YoY
Gross margin
Q2 FY2026
36.1%
Operating margin
Q2 FY2026
9.7%
Key financials
Q2 FY2026| Metric | Q2 FY2026 | YoY | Q1 FY2026 | QoQ |
|---|---|---|---|---|
| Revenue | $0.67B | +65.5% | $0.53B | +24.7% |
| EPS | $1.67 | — | $1.10 | +51.8% |
| Gross margin | 36.1% | — | 34.0% | +210bps |
| Operating margin | 9.7% | — | 1.3% | +840bps |
Guidance
Lumentum delivered a substantial beat on Q2 FY2026 revenue, EPS, and margins while significantly raising Q3 FY2026 guidance across all metrics, with forward EPS and operating margin expected to expand >30% and >450bps respectively.
Guidance is issued for both next quarter and the full year. Both may appear below.
Actuals vs prior guidance
| Metric | Period | Prior guide | Actual | Δ | Result |
|---|---|---|---|---|---|
| Revenue | Q2 FY2026 | $630M to $670M | $665.5M | +$-4.5M below high end, within range but at low end | Beat |
| Non-GAAP EPS | Q2 FY2026 | $1.30 to $1.50 | $1.67 | +$0.17 above high end | Beat |
| Non-GAAP Operating Margin | Q2 FY2026 | 20.0% to 22.0% | 25.2% | +3.2 percentage points above high end | Beat |
New guidance
| Metric | Period | Guide | YoY |
|---|---|---|---|
| Revenue | Q3 FY2026 | $780M to $830M | — |
| Non-GAAP EPS | Q3 FY2026 | $2.15 to $2.35 | — |
| Non-GAAP Operating Margin | Q3 FY2026 | 30.0% to 31.0% | — |
Product revenue
Q2 FY2026| Segment | Q2 FY2026 | YoY |
|---|---|---|
| Components | $0.444B | +68.3% |
| Systems | $0.222B | +60.1% |
Management tone
Narrative arc: Q4 FY25 "AI-driven inflection with $600M target" → Q1 FY26 "$600M pulled forward two quarters; supply the binding constraint" → Q2 FY26 "$750M milestone surpassed; four growth engines with confidence on timing and magnitude."
Pricing has shifted from "untapped lever" to disclosed margin tailwind in two quarters. In Q4 FY25, UBS's question pulled out an explicit admission that pricing was not embedded in either the $600M target or the 40% gross margin target. In Q1 FY26, pricing was conspicuously absent from prepared remarks — margin gains were attributed to mix and yield. This quarter, gross margin printed at 42.5% and the CEO told Raymond James the move into the 40s is partially driven by price actions, with capacity "all on LTAs through end of calendar 2027" and ability to negotiate "incremental pricing for additional volumes" beyond committed amounts. The lever has been pulled — and Q3's 30–31% operating margin guide implies management expects it to keep pulling.
"The vast majority of this growth is still ahead of us" replaces the prior guidance-driven framing. Three quarters of forward markers being compressed have changed the rhetorical center of gravity. The CEO's verbatim line — "the vast majority of this growth is still ahead of us, and we've increased confidence as to the timing and magnitude of the ramps" — is a step beyond the Q1 framing ("next major growth engines") because it claims visibility on both when and how big. For a component vendor that historically guided one quarter forward with caveats, this is a posture change.
OCS escalated from "first revenue" to "$400M+ backlog with broad-based customer adoption" across three quarters. Q4 FY25 booked first revenue with two hyperscalers. Q1 FY26 framed OCS as "next major growth engine not yet contributing meaningfully" with pipelines that had "magnified and multiplied." Q2 FY26 disclosed a $400M+ backlog shipping mostly in fiscal Q1–Q2 FY27 across three customers, with four distinct applications (spine replacement, scale-across, two scale-up variants). Stifel's question confirmed the backlog is genuinely multi-customer, not concentrated.
A fourth growth engine appeared mid-quarter. Last quarter management framed three catalysts (cloud transceivers, OCS, CPO). This quarter introduced optical scale-up as a "generational game-changer" with first scale-up CPO shipments expected by late calendar 2027. The Q&A with Citi adds the ELS module wrinkle: 2–2.5x content versus laser-only, representing entirely new TAM not previously modeled. TAM expansion mid-cycle, paired with capacity that is fully booked through 2027, is the cleanest version of a structural up-cycle disclosure.
Capacity is tracking ahead of plan, but the supply-demand gap is still 25–30%. JP Morgan's exchange disclosed 20% of the planned 40% phosphate capacity increase was achieved in the December quarter alone (vs. a three-quarter plan), with line of sight to additional capacity through four quarters into early 2027 from Sagamahara, Caswell (UK), and a second Japan fab (Kobe). Yet Citi's question pulled out that Lumentum is still "undershipping customers by ~30%." Capacity is being added faster than planned, and demand is still outrunning it.
Recurring themes management leaned on this quarter:
Risks management surfaced:
Q&A highlights
Simon Leopold · Raymond James
Asked for color on OCS market improvement, exit rate, and customer diversification. Also requested quantification of impact from price increases on growth.
OCS backlog exceeded $400 million with most shipping in first two quarters of fiscal 2027. Market developing better than expected with three customers increasing demands significantly. Price increases having modest impact on top-line revenue but more meaningful impact on gross margins, moving into the 40s for the first time.
Samik Chatterjee · JP Morgan
Clarified Indian phosphate capacity ramp timing and impact on 40-50% planned increase. Asked about fab location alternatives (existing vs. new). Also inquired about transceiver business scaling beyond $1 billion and management's ability to manage margins.
Achieved 20% of planned 40% capacity increase in December quarter alone, suggesting better-than-40% overall. Have line of sight to additional capacity increases through H2 2026 into early 2027 from Sagamahara, Caswell (UK), and second Japan fab. Transceiver demand exceeding $1 billion cap; now managing portfolio for both revenue growth and margin expansion with 1.16 lanes having better margins than 800G.
Ryan Coots · Needham & Co.
Asked about transceiver market transition to 1.6T, primary drivers (EML vs. silicon photonics), supplier readiness, and derivative laser opportunities. Also asked about CW laser vertical integration timeline and CPO laser competitive positioning.
1.6T driven primarily by EML demand initially, with 200 gig lane speed hitting 5% mix one quarter earlier than expected. Silicon photonics expected to be majority at 1.6T node, but absolute EML volumes will increase appreciably. CW laser introduction pushed out to late Q2/early Q3 (2-3 month delay). CPO position stronger than transceiver lasers due to proven reliability from subsea applications and 400mW power capability.
Papa Papasila · Citi
Asked about continued visibility from AI customers on EML front and whether supply-demand gap has extended beyond 25-30%. Also inquired about changes to long-term contracts, pricing terms, and content comparison between CPO and transceiver businesses.
Supply-demand imbalance remains 25-30% off from customers' demand despite 20% capacity addition. All EML capacity spoken for through balance of 2027 via long-term agreements (LTAs). Pricing has leeway within LTAs with ability to negotiate incremental pricing for additional units beyond committed volumes. CPO content opportunity enhanced by new external light source (ELS) module opportunity with 2-2.5x ASP gain vs. lasers alone.
Ruben Roy · Stifel
Asked whether OCS backlog momentum is concentrated with single customer or broadening across multiple customers. Inquired about new OCS applications beyond spine replacement. Also asked about 800G vs. 1.6T module mix trajectory.
OCS backlog is broad-based across three customers with stepped-up acceleration to all three. Four dominant applications: spine replacement, scale-across, and two optical scaled-up applications for protection/redundancy. 1.6T accelerating faster than expected 90 days ago, though 800G volume also exceeding expectations. 1.6T growth trend significantly stronger than 800G.
Answers to last quarter's watch list
What to watch into next quarter
Whether Q3 actuals print non-GAAP operating margin above the 31.0% guide high end. Q1 beat its operating margin guide by 120bps, Q2 by 320bps. A third consecutive beat of magnitude would confirm pricing and mix are running structurally ahead of management's own assumptions — and re-anchor the FY27 margin baseline higher.
First disclosure of FY26 full-year dollar revenue range. Management has guided next quarter quantitatively for three straight prints but framed the full year only qualitatively. With Q3 implying >85% YoY growth and OCS/CPO ramps now visibility through H1 FY27, a formal full-year disclosure would be the next escalation in confidence.
Whether OCS backlog disclosed beyond $400M. The $400M figure is "in excess of" and described as supply-constrained. Watch for a discrete backlog quantification with magnitude, or a customer-count update beyond the current three, that would size the FY27 OCS ramp.
CW laser internalization timeline. Pushed out 2–3 months to late Q2/early Q3 of calendar 2026. Watch for confirmation of in-quarter shipment and any gross margin lift attributable to vertical integration — a clean read on the next leg of margin expansion beyond pricing.
Whether transceiver revenue exceeds the previously-communicated $1B run rate, and at what 1.6T mix. Management flagged this in JP Morgan's Q&A. A break-out or discrete commentary in the Q3 print would confirm the $1B was a soft ceiling, not a hard one.
Industrial end-market commentary. Flagged as a risk this quarter without quantification. Watch whether industrial weakness becomes a more discrete drag on Systems or remains immaterial under Components/Systems aggregation.
Sources
- Lumentum Q2 FY2026 Press Release / 8-K Exhibit 99.1, SEC EDGAR — https://www.sec.gov/Archives/edgar/data/1633978/000162828026005005/lite_ex991xq2fy26.htm
- Q&A commentary as captured in extraction inputs (earnings call references)
Get the next brief, free.
We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.
This is not investment advice.